AI-generated summary
This pilot study gave 30 hospitalized adults with cystic fibrosis a bright-light box for 30 minutes daily for seven days after admission for a pulmonary exacerbation. The authors report that depressive symptoms decreased, several quality-of-life measures improved, no adverse events were reported, and length of stay was shorter than in a historical cohort. The study had no control group, so these findings are preliminary.
- Participants
- 30
- Who or what was studied
- Adults hospitalized with cystic fibrosis for pulmonary exacerbation
- Limits stated in the abstract
- As a pilot study, it lacked a control group and hospitalization treatment may have confounded the results on systemic symptoms.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Control group, Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.